[1]张敦熔.现代结核病学.北京:人民军医出版社,2000:96-98.[2]Musser JM. Antimicrobial agent resistance in mycobacteria: molecular genetic insights(Review). Clin Microbiol Rev, 1995, 8(4):496-514.[3]Nachamkin I, Kang C, Weinstein MP. Detection of resistance to isoniazid, rifampin, and streptomycin in clinical isolates of Mycobacterium tuberculosis by molecular methods. Clin Infect Dis, 1997,24(5):894-900.[4]Jou R, Chen HY, Chiang CY, et al. Genetic diversity of multidrug-resistant Mycobacterium tuberculosis isolates and identification of 11 novel rpoB alleles in Taiwan. J Clin Microbiol, 2005, 43(3):1390-1394.[5]Bolotin S, Alexander DC, Chedore P, et al. Molecular characterization of drug-resistant Mycobacterium tuberculosis isolates from Ontario, Canada. J Antimicrob Chemother,2009,64(2):263-266.[6]Musser JM, Kapur V, Williams DL,et al. Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. J Infect Dis, 1996,173(1):196-202.[7]Luckner SR, Liu N, am Ende CW, et al. A slow, tight binding inhibitor of InhA, the enoyl-acyl carrier protein reductase from Mycobacterium tuberculosis. J Biol Chem,2010,285(19):14330-14337.[8]Dessen A, Quémard A, Blanchard JS, et al.Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis. Science,1995,267(5204): 1638-1641.[9]Drobniewski FA, Watterson SA, Wilson SM,et al.A clinical, microbiological and economic analysis of a national service for the rapid molecular diagnosis of tuberculosis and rifampicin resistance in Mycobacterium tuberculosis. J Med Microbiol,2000,49(3):271-278.[10]Chaoui I, Sabouni R, Kourout M,et al.Analysis of isoniazid, streptomycin and ethambutol resistance in Mycobacterium tuberculosis isolates from Morocco. J Infect Dev Ctries,2009,3(4):278-284.[11]Banerjee A, Dubnau E, Quemard A,et al.InhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science,1994, 263(5144):227-230.[12]梁莉, 乐军, 李瑶,等.利用基因芯片技术检测结核分支杆菌耐利福平分离株rpoB 基因突变的研究.中华医院感染学杂志,2005,15(8):841-844.[13]Aragón LM, Navarro F, Heiser V, et al. Rapid detection of specific gene mutations associated with isoniazid or rifampicin resistance in Mycobacterium tuberculosis clinical isolates using nonfluorescent lowdensity DNA microarrays. J Antimicrob Chemother, 2006, 57(5):825-831.[14]郭乃洲,王万相,严爱华,等.显色法芯片检测结核分枝杆菌利福平和异烟肼耐药基因.中华微生物学和免疫学杂志,2006,26(6):567-570.[15]袁瑛,顾德林,顾红艳.耐多药结核分枝杆菌KatG及rpoB基因变异的研究.临床荟萃,2006,21(12):863-864.[16]菅记涌,王嫩寒,易俊莉,等.MTBDR plus方法快速检测北京地区临床结核分枝杆菌分离株利福平和异烟肼耐药性效果评价.中国防痨杂志,2010,32(10):611-614.[17]Morris S, Bai GH, Suffys P, et al. Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis. J Infect Dis, 1995,171(4):954-960. |